Aaron N. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aaron N. Smith has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Debra K. Sullivan
University of Kansas Medical Center
3 shared publicationsJeffrey M. Burns
University of Kansas
3 shared publicationsAaron F. Carbuhn
University of Kansas Medical Center
2 shared publicationsJessica E. Keller
University of Kansas Medical Center
2 shared publicationsMatthew K. Taylor
University of Kansas Medical Center
2 shared publications- Matthew K. Taylor
Department of Dietetics and Nutrition University of Kansas Medical Center Kansas City Kansas USA
2 shared publications
Latest Publications
- 30 September 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
APOE4 is associated with lower adiposity independent of total energy intake in cognitively normal older adults
Background: Apolipoprotein E ε4 ( APOE4) carriers with cognitive impairment exhibit lower BMI than non-carriers, but whether APOE4 influences body composition in cognitively normal older adults remains unknown. Objective: To examine the association between APOE4 carrier status and body composition in cognitively normal older adults. Methods: Cross-sectional analysis of 203 cognitively normal older adults (mean age 71.4 ± 4.8 years). Body composition was assessed via dual-energy x-ray absorptiometry. Linear regression models adjusted for age, sex, total energy intake, and physical activity examined associations between APOE4 status and BMI, body fat percentage, fat mass index (FMI), and lean mass index (LMI). Results: APOE4 carriers (32%, n = 65) had lower BMI (β = −1.42 kg/m 2 , p = 0.043), body fat percentage (β = −3.56%, p < 0.001), and FMI (β = −1.51 kg/m 2 , p = 0.002) compared to non-carriers (68%, n = 138). LMI did not differ between groups (β = 0.18 kg/m 2 , p = 0.43). Conclusions: APOE4 carriers exhibited lower adiposity but not lean mass compared to non-carriers, independent of total energy intake and physical activity. These findings suggest APOE4 influences fat mass through metabolic mechanisms that emerge before cognitive decline. Longitudinal studies are needed to determine whether these differences contribute to AD pathogenesis.
- 30 September 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
APOE4 is associated with lower adiposity independent of total energy intake in cognitively normal older adults
Background: Apolipoprotein E ε4 ( APOE4) carriers with cognitive impairment exhibit lower BMI than non-carriers, but whether APOE4 influences body composition in cognitively normal older adults remains unknown. Objective: To examine the association between APOE4 carrier status and body composition in cognitively normal older adults. Methods: Cross-sectional analysis of 203 cognitively normal older adults (mean age 71.4 ± 4.8 years). Body composition was assessed via dual-energy x-ray absorptiometry. Linear regression models adjusted for age, sex, total energy intake, and physical activity examined associations between APOE4 status and BMI, body fat percentage, fat mass index (FMI), and lean mass index (LMI). Results: APOE4 carriers (32%, n = 65) had lower BMI (β = −1.42 kg/m 2 , p = 0.043), body fat percentage (β = −3.56%, p < 0.001), and FMI (β = −1.51 kg/m 2 , p = 0.002) compared to non-carriers (68%, n = 138). LMI did not differ between groups (β = 0.18 kg/m 2 , p = 0.43). Conclusions: APOE4 carriers exhibited lower adiposity but not lean mass compared to non-carriers, independent of total energy intake and physical activity. These findings suggest APOE4 influences fat mass through metabolic mechanisms that emerge before cognitive decline. Longitudinal studies are needed to determine whether these differences contribute to AD pathogenesis.
- 23 April 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 111 (4) , 1881-1891
Larger baseline body stature predicts one-year amyloid change in cognitively normal older adults enriched with elevated amyloid status
Background: Rising Alzheimer's disease (AD) incidence underscores the need to identify modifiable risk factors. The “obesity paradox” suggests higher late-life body mass index (BMI) may reduce AD risk. Because BMI does not distinguish between fat and lean mass, investigating body composition and brain amyloid accumulation may clarify this relationship. Objective: This study tested whether baseline body stature predicts one-year change in brain amyloid. Methods: Using data from the Alzheimer's Prevention through Exercise trial, we examined whether baseline body stature and composition (BMI, fat mass index [FMI], lean mass index [LMI], and total fat and lean mass) predicted one-year change in brain amyloid among 106 cognitively healthy older adults enriched with elevated amyloid status. Results: Higher baseline BMI predicted less one-year amyloid accumulation globally (β = −0.33, p = 0.001) and in five of six brain regions (p = 0.001–0.05). Higher FMI predicted less amyloid accumulation globally (β = −0.35, p < 0.001) and in all six regions (p < 0.001–0.02), while higher LMI predicted less accumulation globally and in four regions (p < 0.001–0.02). Higher total fat mass was associated with less amyloid globally and regionally (p < 0.001–0.02), whereas higher total lean mass predicted reduced accumulation only in the lateral temporal lobe (p = 0.01). Conclusions: Larger body mass predicted less amyloid accumulation in cognitively healthy older adults over one year. More research is needed to investigate whether larger body stature protects against amyloid accumulation and explore underlying mechanisms. Clinical Trial Registration: ClinicalTrials.gov, Identifier (NCT02000583).
- 23 April 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 111 (4) , 1881-1891
Larger baseline body stature predicts one-year amyloid change in cognitively normal older adults enriched with elevated amyloid status
Background: Rising Alzheimer's disease (AD) incidence underscores the need to identify modifiable risk factors. The “obesity paradox” suggests higher late-life body mass index (BMI) may reduce AD risk. Because BMI does not distinguish between fat and lean mass, investigating body composition and brain amyloid accumulation may clarify this relationship. Objective: This study tested whether baseline body stature predicts one-year change in brain amyloid. Methods: Using data from the Alzheimer's Prevention through Exercise trial, we examined whether baseline body stature and composition (BMI, fat mass index [FMI], lean mass index [LMI], and total fat and lean mass) predicted one-year change in brain amyloid among 106 cognitively healthy older adults enriched with elevated amyloid status. Results: Higher baseline BMI predicted less one-year amyloid accumulation globally (β = −0.33, p = 0.001) and in five of six brain regions (p = 0.001–0.05). Higher FMI predicted less amyloid accumulation globally (β = −0.35, p < 0.001) and in all six regions (p < 0.001–0.02), while higher LMI predicted less accumulation globally and in four regions (p < 0.001–0.02). Higher total fat mass was associated with less amyloid globally and regionally (p < 0.001–0.02), whereas higher total lean mass predicted reduced accumulation only in the lateral temporal lobe (p = 0.01). Conclusions: Larger body mass predicted less amyloid accumulation in cognitively healthy older adults over one year. More research is needed to investigate whether larger body stature protects against amyloid accumulation and explore underlying mechanisms. Clinical Trial Registration: ClinicalTrials.gov, Identifier (NCT02000583).
- Open Access
- 29 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
The Future is Now - Emerging Trends in the Older Adult: Proceedings of the 8th Annual Virtual Conference of the Healthy Aging Dietetic Practice Group (Preprint)
UNSTRUCTURED Expert insight on nutrition and healthy aging along with concise takeaways for practitioners were developed from the 8th Annual Virtual Conference of the Healthy Aging Dietetic Practice Group. With six distinguished professionals presenting on an array of topics, the conference highlighted both emerging trends and advances in established practices in the field. The first topic explored the safe implementation of a low-carbohydrate diet, elucidating its effects on metabolic health and discussed both the best uses and contraindications. The second lecture focused on continuous glucose monitoring in older adults with diabetes, emphasizing the role of technology in improving glycemic control and patient outcomes. In the third expert lecture, the discussion surrounded the adaptation of the Diabetes Prevention Program (a landmark lifestyle intervention) for older adults, underscoring the need for tailored, age-specific strategies and tactics. The fourth lecture addressed the importance of providing culturally appropriate patient care in dietetics, highlighting the nuances of dietary habits across diverse cultures and cuisines. In the fifth presentation, the speaker deconstructed the concept of “anti-aging” or longevity diets, separating fact from fiction and providing evidence-based insights into emerging nutritional therapies to extend lifespan, including counter-intuitive dietary approaches like protein restriction and calorie restriction. Lastly, the conference was wrapped up with a discussion on the aging brain, highlighting the relationship between nutrient-rich diets and cognitive function in older adults, including key micronutrient needs and the impact of multivitamin supplementation. Overall, the conference served as a platform for knowledge exchange and emphasized the pivotal role of dietetics in promoting healthy aging and longevity.
- 29 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Future is Now - Emerging Trends in the Older Adult: Proceedings of the 8th Annual Virtual Conference of the Healthy Aging Dietetic Practice Group (Preprint)
UNSTRUCTURED Expert insight on nutrition and healthy aging along with concise takeaways for practitioners were developed from the 8th Annual Virtual Conference of the Healthy Aging Dietetic Practice Group. With six distinguished professionals presenting on an array of topics, the conference highlighted both emerging trends and advances in established practices in the field. The first topic explored the safe implementation of a low-carbohydrate diet, elucidating its effects on metabolic health and discussed both the best uses and contraindications. The second lecture focused on continuous glucose monitoring in older adults with diabetes, emphasizing the role of technology in improving glycemic control and patient outcomes. In the third expert lecture, the discussion surrounded the adaptation of the Diabetes Prevention Program (a landmark lifestyle intervention) for older adults, underscoring the need for tailored, age-specific strategies and tactics. The fourth lecture addressed the importance of providing culturally appropriate patient care in dietetics, highlighting the nuances of dietary habits across diverse cultures and cuisines. In the fifth presentation, the speaker deconstructed the concept of “anti-aging” or longevity diets, separating fact from fiction and providing evidence-based insights into emerging nutritional therapies to extend lifespan, including counter-intuitive dietary approaches like protein restriction and calorie restriction. Lastly, the conference was wrapped up with a discussion on the aging brain, highlighting the relationship between nutrient-rich diets and cognitive function in older adults, including key micronutrient needs and the impact of multivitamin supplementation. Overall, the conference served as a platform for knowledge exchange and emphasized the pivotal role of dietetics in promoting healthy aging and longevity.
- Open Access
- 29 September 2023
- Published by Elsevier in Current Developments in Nutrition
- Vol. 7 (11) , 102011
Creatine as a Therapeutic Target in Alzheimer's Disease
- 29 September 2023
- Published by Elsevier in Current Developments in Nutrition
- Vol. 7 (11) , 102011
Open AccessCreatine as a Therapeutic Target in Alzheimer's Disease
- 2 November 2021
- Published by Elsevier in Journal of Food Composition and Analysis
- Vol. 105
Correlation of skin carotenoid content with 3-day dietary intake in community dwelling older adults
- 2 November 2021
- Published by Elsevier in Journal of Food Composition and Analysis
- Vol. 105
Correlation of skin carotenoid content with 3-day dietary intake in community dwelling older adults